These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22881285)

  • 1. Association study of a polymorphism in clock gene PERIOD3 and risk of inflammatory bowel disease.
    Mazzoccoli G; Palmieri O; Corritore G; Latiano T; Bossa F; Scimeca D; Biscaglia G; Valvano MR; D'Incà R; Cucchiara S; Stronati L; Annese V; Andriulli A; Latiano A
    Chronobiol Int; 2012 Oct; 29(8):994-1003. PubMed ID: 22881285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease.
    Khazen D; Jendoubi-Ayed S; Aleya WB; Sfar I; Mouelhi L; Matri S; Najjar T; Filali A; Gorgi Y; Abdallah TB; Ayed K
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):167-75. PubMed ID: 19212205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease.
    Senhaji N; Serbati N; Diakité B; Arazzakou S; Hamzi K; Badre W; Nadifi S
    Gene; 2013 May; 521(1):45-9. PubMed ID: 23542077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a CXCL9 polymorphism with pediatric Crohn's disease.
    Lacher M; Kappler R; Berkholz S; Baurecht H; von Schweinitz D; Koletzko S
    Biochem Biophys Res Commun; 2007 Nov; 363(3):701-7. PubMed ID: 17892861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease.
    Latiano A; Palmieri O; Cucchiara S; Castro M; D'Incà R; Guariso G; Dallapiccola B; Valvano MR; Latiano T; Andriulli A; Annese V
    Am J Gastroenterol; 2009 Jan; 104(1):110-6. PubMed ID: 19098858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease.
    Cucchiara S; Latiano A; Palmieri O; Canani RB; D'Incà R; Guariso G; Vieni G; De Venuto D; Riegler G; De'Angelis GL; Guagnozzi D; Bascietto C; Miele E; Valvano MR; Bossa F; Annese V;
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):171-9. PubMed ID: 17255827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
    Glas J; Seiderer J; Pasciuto G; Tillack C; Diegelmann J; Pfennig S; Konrad A; Schmechel S; Wetzke M; Török HP; Stallhofer J; Jürgens M; Griga T; Klein W; Epplen JT; Schiemann U; Mussack T; Lohse P; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Mar; 104(3):665-72. PubMed ID: 19262523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the influence of two CD24 genetic variants in Crohn's disease and ulcerative colitis.
    Diaz-Gallo LM; Medrano LM; Gómez-García M; Cardeña C; Rodrigo L; Mendoza JL; Taxonera C; Nieto A; Alcain G; Cueto I; López-Nevot MA; Urcelay E; Martin J
    Hum Immunol; 2011 Oct; 72(10):969-72. PubMed ID: 21684315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease.
    Rector A; Lemey P; Laffut W; Keyaerts E; Struyf F; Wollants E; Vermeire S; Rutgeerts P; Van Ranst M
    Genes Immun; 2001 Oct; 2(6):323-8. PubMed ID: 11607788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.
    Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
    Int J Immunogenet; 2005 Dec; 32(6):401-5. PubMed ID: 16313306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis.
    Márquez L; Shen C; Cleynen I; De Hertogh G; Van Steen K; Machiels K; Perrier C; Ballet V; Organe S; Ferrante M; Henckaerts L; Galicia G; Rutgeerts P; Ceuppens JL; Vermeire S
    Gut; 2012 Apr; 61(4):528-34. PubMed ID: 21708824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency.
    Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C
    Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
    Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH
    Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.